Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 208
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01638286 | Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects | ||
| NCT03330327 | Molar Potency Study of HM12470 in Healthy Subjects | ||
| NCT01746771 | A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer | ||
| NCT02916602 | A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605 | ||
| NCT04252963 | Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase) | ||
| NCT04654702 | Observational Study to Evaluate Therapeutic Effectiveness and Safety of Monterizine Cap. | ||
| NCT01448330 | A Bioequivalence Study Comparing Clopidogrel/Aspirin Combination Tablet With Coadministration of Clopidogrel and Aspirin | ||
| NCT00942344 | Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension | ||
| NCT02418689 | Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens | ||
| NCT02940314 | Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers | ||
| NCT05723549 | A Study to Evaluate the PK, Safety and Tolerability of HCP1803. | ||
| NCT02205606 | Efficacy/Safety of HCP1306 Tablet Versus HGP0816 Tablet in Patients With Primary Hypercholesterolemia | ||
| NCT02473900 | Evaluating the Bioequivalence of HIP1403, HGP0919 | ||
| NCT05191563 | A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination of HCP1904 and Co-Administration of RLD2001-2 and RLD2006 Tablets in Healthy Subjects. | ||
| NCT03684642 | Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin | ||
| NCT01651481 | Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination | ||
| NCT03372850 | Safety, Pharmacokinetics and Pharmacodynamics of the Two Esomeprazole Formulations | ||
| NCT01822340 | Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients | ||
| NCT04768686 | FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer | ||
| NCT05737082 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2201 and Co-administration of Each Component in Healty Male Volunteers | ||
| NCT07939087 | A Study to Evaluate the Pharmacokinetics and Safety Between HIP2604 and RLD2606 in Healthy Volunteers | ||
| NCT06518122 | A Study to Evaluate the Drug-drug Interaction and Safety Between HCP1306, RLD2302 and RLD2102 in Healthy Volunteers | ||
| NCT06438172 | A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential Hypertension | ||
| NCT04788290 | An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol | ||
| NCT04967014 | Study to Evaluate the Safety and Pharmacodynamic/Pharmacokinetic Characteristics of HIP2101 in Healthy Volunteers | ||
| NCT04652349 | Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia | ||
| NCT07449754 | Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma | ||
| NCT06174779 | A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus | ||
| NCT05407220 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1904 in Healthy Male Volunteers. | ||
| NCT03744182 | A Study of Multiple Doses of HM15211(Efocipegtrutide) in Obese Subjects With NAFLD | ||
| NCT06357910 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions | ||
| NCT05487560 | An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding | ||
| NCT02941679 | Clinical Efficacy and Safety Evaluation of HCP1202 in COPD Patients | ||
| NCT04322266 | A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects. | ||
| NCT04325620 | Safety to Evaluate the Efficacy and Safety of HIP1601 in Patients With Non Erosive Reflux Disease | ||
| NCT02587988 | Trial to Evaluate the Efficacy and Safety of HCP1302 | ||
| NCT02302443 | A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470 | ||
| NCT03897868 | A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential Hypertension | ||
| NCT05024721 | Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis | ||
| NCT01929512 | Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg | ||
| NCT04204629 | Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects | ||
| NCT04081844 | A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects. | ||
| NCT02444819 | Phase II Trial to Evaluate the Efficacy and Safety of HM61713 as the 1st-line NSCLC Anticancer Therapy | ||
| NCT04505436 | Efocipegtrutide (HM15211) in Adults With Biopsy-Confirmed Nonalcoholic Steatohepatitis (NASH) | ||
| NCT05548387 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers | ||
| NCT01555398 | Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 Capsule | ||
| NCT04167553 | Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities | ||
| NCT01588145 | Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients | ||
| NCT04252872 | Pharmacokinetics of HCP1401 and Co-administration of HCP0605, HGP1405 in Healthy Male Volunteers | ||
| NCT07205900 | Study to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus |
